For outside the US and Canada/or Canada only
Product availability subject to required regulatory approvals

Diasorin, The Diagnostic Specialist

We are global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments. For over 50 years our Group has been developing, producing and commercializing diagnostic tests: we support clinical laboratory needs and activities, providing solutions that are reliable, innovative, fully automated and standardized. We continually invest in Research & Development, using our own distinctive expertise in the field to deliver a high level of innovation.

Our Company

Clinical Areas

We offer the broadest range of specialty tests available in the immunodiagnostics market.
Discover All Areas Discover Our Menu

LIAISON® XL

LIAISON® XL is the fully automated chemiluminescence analyzer, performing complete sample processing (sample pre-dilutions, sample and reagent dispensing, incubations, wash processes, etc.) as well as measurement and evaluation. The innovative features of the system allow LIAISON® XL to improve efficiency in the immunoassay laboratories: fully automated solution, quality of results, flexible configuration, high efficiency.
Discover All Systems

Worldwide Presence

Our Group consists of 24 companies and 5 foreign branches, with offices across 5 continents and manufacturing premises producing its tests in 6 sites around the world.
Where we are

News

01/31/2019
DiaSorin launches FDA-Cleared LIAISON® Calprotectin test in the US market
09/17/2018
DiaSorin launches the new LIAISON® QUANTIFERON®-TB GOLD PLUS ASSAY as an aid for latent tuberculosis
07/27/2018
DiaSorin launches Hepatitis Delta (Hdv) test on LIAISON® XL platform
05/23/2017
DiaSorin launches the new LIAISON® SHBG test for the diagnosis of androgen-related disorders
All News